CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2008; 58:231-244
© 2008 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
Economic Evaluations of Medical Care Interventions for Cancer Patients: How...
Right arrow Data Supplement
Right arrow Submit a letter to the editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, Y.-C. T.
Right arrow Articles by Halpern, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shih, Y.-C. T.
Right arrow Articles by Halpern, M. T.

Economic Evaluations of Medical Care Interventions for Cancer Patients

How, Why, and What Does it Mean?

Ya-Chen Tina Shih, PhD and Michael T. Halpern, MD, PhD

Dr. Shih is Associate Professor, Section of Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX.
Dr. Halpern is Strategic Director, Health Services Research, American Cancer Society, Atlanta, GA.

Disclosure: No outside financial support was provided for this manuscript, and no conflict of interest exists.

Published online through CA First Look at http://CAonline.AmCancer.Soc.org.
To earn free CME credit for successfully completing the online quiz based on this article, go to http://CME.AmCancerSoc.org.

While the past decade has seen the development of multiple new interventions to diagnose and treat cancer, as well as to improve the quality of life for cancer patients, many of these interventions have substantial costs. This has resulted in increased scrutiny of the costs of care for cancer, as well as the costs relative to the benefits for cancer treatments. It is important for oncologists and other members of the cancer community to consider and understand how economic evaluations of cancer interventions are performed and to be able to use and critique these evaluations. This review discusses the components, main types, and analytic issues of health economic evaluations using studies of cancer interventions as examples. We also highlight limitations of these economic evaluations and discuss why members of the cancer community should care about economic analyses.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
D. Greenberg, C. Earle, C.-H. Fang, A. Eldar-Lissai, and P. J. Neumann
When is Cancer Care Cost-Effective? A Systematic Overview of Cost-Utility Analyses in Oncology
J Natl Cancer Inst, January 20, 2010; 102(2): 82 - 88.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

eLetter for "Economic evaluations of medical care interventions for cancer patients"
Arumugam Manoharan
CA Online, 1 Aug 2008 [Full text]
Editor's Note
Ted Gansler, MD, MBA
CA Online, 1 Aug 2008 [Full text]
Ethical dimension and economic evaluation in cancer therapy: is cooperation possible?
Antonio Jirillo, et al.
CA Online, 29 Aug 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by American Cancer Society.